Janux Therapeutics (JANX) Non Operating Income (2020 - 2026)
Janux Therapeutics' Non Operating Income came in at $9.72 million for Q2 2026, down 13.7% from $11.26 million a year earlier and down 1.4% from the prior quarter.
Janux Therapeutics (JANX) Non Operating Income (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Janux Therapeutics reported Non Operating Income of $40.96 million, up 4.4% year-over-year; for FY2025, it came in at $44.04 million, up 47.5% from FY2024.
- Non Operating Income has increased in each of the last three years.
- Going back by year, Non Operating Income was $29.85 million in FY2024 (+103.3%), $14.69 million in FY2023 (+264.2%), $4.03 million in FY2022 and $257,000 in FY2021.
- The Q2 2026 figure represents the lowest quarterly Non Operating Income since Q4 2024.
- Year-over-year, Non Operating Income increased in six of the last eight quarters, with growth averaging 46.3%.
- The fastest year-over-year change in Non Operating Income over five years came in Q3 2022 (growth of 867.9%), and the weakest in Q2 2026 (a decline of 13.7%).
- Business Quant data shows JANX's Non Operating Income at $9.85 million (Q1 2026), $10.46 million (Q4 2025) and $10.94 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Janux Therapeutics | 1.06 Bn | 1.06 Bn | - | 9.72 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.72 Mn |
| Mar 31, 2026 | 9.85 Mn |
| Dec 31, 2025 | 10.46 Mn |
| Sep 30, 2025 | 10.94 Mn |
| Jun 30, 2025 | 11.26 Mn |
| Mar 31, 2025 | 11.39 Mn |
| Dec 31, 2024 | 8.81 Mn |
| Sep 30, 2024 | 7.78 Mn |
| Jun 30, 2024 | 7.86 Mn |
| Mar 31, 2024 | 5.40 Mn |
| Dec 31, 2023 | 4.38 Mn |
| Sep 30, 2023 | 4.25 Mn |
| Jun 30, 2023 | 3.24 Mn |
| Mar 31, 2023 | 2.82 Mn |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | 373,000.00 |
| Mar 31, 2022 | 132,000.00 |
| Dec 31, 2021 | 74,000.00 |
| Sep 30, 2021 | 137,000.00 |
Janux Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=JANX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "JANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=JANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();